Cancer immunotherapy researchers at Mass General are identifying powerful new targets by using the immune system to fight cancer — bringing new hope to patients and changing the future course of cancer treatment.
For some time, there has been evidence to suggest a drug used to treat type 2 diabetes could slow certain types of cancers. Until now, we didn’t know why.
Brian Sheehan and David Richter have personal reasons for co-chairing the first Everyday Amazing Race, which will benefit research and care at the Mass General Cancer Center.
A medical oncologist and a palliative care provider collaborate to compassionately guide patients and their families through the cancer journey.
The Mass General Cancer Center tackles the dual challenge of treating cancer patients who also have substance use disorders with an innovative approach.
Diagnosed with a rare uterine-ovarian cancer, Diane Redington embarked upon an ambitious fundraising and educational campaign focused on finding a cure.
After a daunting diagnosis, a successful businesswoman draws on her background to create a foundation to support patients as well as research.
A mother of two and her family support pancreatic cancer research after a new high-tech treatment at Mass General helped her survive the disease.
Inspired by his two sisters’ battles with breast cancer, Jimmy Doan is running his first Boston Marathon this year to support Mass General.
Elizabeth Duquette wasn’t certain she was up to running the Boston Marathon until a young patient vowed to launch a petition drive to persuade her.
